Multiple Sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous system that affects millions of individuals worldwide. The disease is characterized by a variety of neurological symptoms
Purpose: The previous meta-analyses have illustrated that Multiple Sclerosis (MS) is correlated with multiple health outcomes. We designed an umbrella meta-analysis to evaluate the breadth, validity and presence
laser device with an extremely low energy level in treating severe neurological disease -multiple sclerosis. This report describes the results of a study using a “device to remote transfer ... acyclovir were used to…
development. Further research into the relationship between Saccharomyces, Candida, and other microbiome components in multiple sclerosis is necessary. Investigating fungi's role in disease progression or prevention is…
Introduction Multiple Sclerosis (MS) is a chronic, immune-mediated inflammatory disease of the central nervous system that results in myelin destruction in the brain and spinal cord. Substance abuse disorder ... data…
administration of this new infection, even in sufferers with different ailments such as Multiple Sclerosis (MS). Three huge questions continue to be open: how does this new contamination happen itself
Objective: Multiple Sclerosis (MS) causes many disabling symptoms that can lead to physical and psychological burden for patients. Pain and spasticity are common MS symptoms that affect patient’s quality ... Cochrane…
Background Multiple sclerosis is a chronic, demyelinating disease that requires treatment decisions at multiple points in the disease course. Shared decision-making (SDM) is an approach to treatment decision-making…
links enlarged VRS to clinical measures of disease severity across various neurological conditions. In Multiple Sclerosis (MS), while some studies suggest associations with lesion volume and disease severity, a meta
emerged as a successful intervention for alleviating depressive symptoms in individuals with Multiple Sclerosis (MS), offering both in-person and internet-based options. Stefan M. Gold and colleagues conducted
Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system, characterized by inflammation, demyelination, and neurodegeneration. Pregnancy often induces fluctuations in disease activity, with…
into the intriguing relationship between Adverse Childhood Experiences (ACEs) and the risk of developing Multiple Sclerosis (MS). While extensive research has connected early life adversity to various health outcomes…
expert opinions on the integration of patient-reported outcomes (PROs) in the treatment of multiple sclerosis (MS). As a chronic neurological condition with diverse symptomatology, MS management extends beyond clinical
Multiple Sclerosis (‘MS’) is a chronic neurological disorder characterised by immune-mediated damage to the central nervous system. Ocrelizumab (‘OCR’) is a novel disease-modifying therapy that has shown promising
sole approved disease-modifying therapy for both relapsing and primary progressive forms of Multiple Sclerosis (MS). Recognized by regulatory authorities, Ocrelizumab's approval marks a pivotal shift, offering a unified
heterogeneous nature of multiple sclerosis (MS) and the unavailability of treatments addressing its intricate network and reversing the disease state is yet an area that needs to be elucidated. Liraglutide
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.